Cargando…

Progressive in vivo development of resistance to cefiderocol in Pseudomonas aeruginosa

We report in vivo development of cefiderocol (FDC) resistance among four sequential Pseudomonas aeruginosa clinical isolates ST244 recovered from a single patient, without exposure to FDC, which raises concern about the effectiveness of this novel drug. The first recovered P. aeruginosa isolate (P-0...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sadek, Mustafa, Le Guern, Rémi, Kipnis, Eric, Gosset, Philippe, Poirel, Laurent, Dessein, Rodrigue, Nordmann, Patrice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816264/ https://www.ncbi.nlm.nih.gov/pubmed/36376766 http://dx.doi.org/10.1007/s10096-022-04526-0

Ejemplares similares

Gut colonisation with multidrug-resistant Klebsiella pneumoniae worsens Pseudomonas aeruginosa lung infection
por: Le Guern, Rémi, et al.
Publicado: (2023)

Draft Genome Sequences of Two Pseudomonas aeruginosa Multidrug-Resistant Clinical Isolates, PAL0.1 and PAL1.1
por: Grandjean, Teddy, et al.
Publicado: (2018)

Draft Genome Sequences of Two Carbapenemase-Producing Klebsiella pneumoniae Strains Isolated from Blood Cultures
por: Le Guern, Rémi, et al.
Publicado: (2018)

Antibiotic-related gut dysbiosis induces lung immunodepression and worsens lung infection in mice
por: Dessein, Rodrigue, et al.
Publicado: (2020)

Rapid detection of cefiderocol susceptibility/resistance in Acinetobacter baumannii
por: Raro, Otávio Hallal Ferreira, et al.
Publicado: (2023)

Protective role of murine norovirus against Pseudomonas aeruginosa acute pneumonia
por: Thépaut, Marion, et al.
Publicado: (2015)

In vitro activity of cefepime/zidebactam and cefepime/taniborbactam against aztreonam/avibactam-resistant NDM-like-producing Escherichia coli clinical isolates
por: Le Terrier, Christophe, et al.
Publicado: (2023)

Genomic Characterization of an Extensively Drug-Resistant Extra-Intestinal Pathogenic (ExPEC) Escherichia coli Clinical Isolate Co-Producing Two Carbapenemases and a 16S rRNA Methylase
por: Sadek, Mustafa, et al.
Publicado: (2022)

Tryptophan catabolism in Pseudomonas aeruginosa and potential for inter-kingdom relationship
por: Bortolotti, Perrine, et al.
Publicado: (2016)

Carbapenem-hydrolyzing metallo-beta-lactamase from a nosocomial isolate of Pseudomonas aeruginosa in France.
por: Poirel, L, et al.
Publicado: (2000)

VEB-1-like extended-spectrum beta-lactamases in Pseudomonas aeruginosa, Kuwait.
por: Poirel, L, et al.
Publicado: (2001)

RapidResa Polymyxin Acinetobacter NP(®) Test for Rapid Detection of Polymyxin Resistance in Acinetobacter baumannii
por: Bouvier, Maxime, et al.
Publicado: (2021)

Cefiderocol is an effective topical monotherapy for experimental extensively-drug resistant Pseudomonas aeruginosa keratitis
por: Romanowski, Eric G., et al.
Publicado: (2023)

Combination of phage therapy and cefiderocol to successfully treat Pseudomonas aeruginosa cranial osteomyelitis
por: Simner, Patricia J., et al.
Publicado: (2022)

In Vitro Activity of Cefiderocol against Extensively Drug-Resistant Pseudomonas aeruginosa: CANWARD, 2007 to 2019
por: Karlowsky, James A., et al.
Publicado: (2022)

Crystal Structure of DIM-1, an Acquired Subclass B1 Metallo-β-Lactamase from Pseudomonas stutzeri
por: Booth, Michael P. S., et al.
Publicado: (2015)

Education: A compassionate use of cefiderocol to treat osteomyelitis caused by an XDR Pseudomonas aeruginosa
por: Chavda, A, et al.
Publicado: (2021)

Cefiderocol Activity Against Clinical Pseudomonas aeruginosa Isolates Exhibiting Ceftolozane-Tazobactam Resistance
por: Simner, Patricia J, et al.
Publicado: (2021)

Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria
por: Nordmann, Patrice, et al.
Publicado: (2019)

P44 Nosocomial neurosurgical meningitis due to XDR Pseudomonas aeruginosa: clinical experience with cefiderocol
por: Stevenson, D. R., et al.
Publicado: (2022)

648. Cefiderocol as Rescue Therapy for Pseudomonas aeruginosa and Other Difficult-To-Treat Gram-Negative Infections
por: Chou, Andrew, et al.
Publicado: (2022)

Cefiderocol Treatment for Patients with Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa Infections in the Compassionate Use Program
por: Satlin, Michael J., et al.
Publicado: (2023)

2750. Pseudomonas aeruginosa infections treated with cefiderocol: associations of site of infection and time to first dose with outcomes in PROVE (Retrospective Cefiderocol Chart Review) Study
por: Marcella, Stephen, et al.
Publicado: (2023)

Rapid Detection of Carbapenemase-producing Enterobacteriaceae
por: Nordmann, Patrice, et al.
Publicado: (2012)

Worldwide Dissemination of the NDM-Type Carbapenemases in Gram-Negative Bacteria
por: Dortet, Laurent, et al.
Publicado: (2014)

Rapid Detection of ESBL-Producing Enterobacteriaceae in Blood Cultures
por: Dortet, Laurent, et al.
Publicado: (2015)

Siderophore Cephalosporin Cefiderocol Utilizes Ferric Iron Transporter Systems for Antibacterial Activity against Pseudomonas aeruginosa
por: Ito, Akinobu, et al.
Publicado: (2016)

Genomic Features of MCR-1 and Extended-Spectrum β-Lactamase-Producing Enterobacterales from Retail Raw Chicken in Egypt
por: Sadek, Mustafa, et al.
Publicado: (2021)

Global Spread of Carbapenemase-producing Enterobacteriaceae
por: Nordmann, Patrice, et al.
Publicado: (2011)

Plasmid-Mediated Quinolone Resistance; Interactions between Human, Animal, and Environmental Ecologies
por: Poirel, Laurent, et al.
Publicado: (2012)

Rapid Detection of Polymyxin Resistance in Enterobacteriaceae
por: Nordmann, Patrice, et al.
Publicado: (2016)

Efficacy of ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam combinations against carbapenemase-producing Enterobacterales in Switzerland
por: Nordmann, Patrice, et al.
Publicado: (2023)

Rapid detection of temocillin resistance in Enterobacterales
por: Findlay, Jacqueline, et al.
Publicado: (2023)

Activity of Cefiderocol Against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Endemic to Medical Centers in New York City
por: Iregui, Alejandro, et al.
Publicado: (2020)

Cefiderocol for treatment of an empyema due to extensively drug-resistant Pseudomonas aeruginosa: Clinical observations and susceptibility testing considerations
por: Kufel, Wesley D., et al.
Publicado: (2020)

Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections
por: Meschiari, Marianna, et al.
Publicado: (2021)

New Delhi Metallo-β-Lactamase 4–producing Escherichia coli in Cameroon
por: Dortet, Laurent, et al.
Publicado: (2012)

National survey of colistin resistance among carbapenemase-producing Enterobacteriaceae and outbreak caused by colistin-resistant OXA-48-producing Klebsiella pneumoniae, France, 2014
por: Jayol, Aurélie, et al.
Publicado: (2016)

First Genomic Characterization of bla(VIM-1) and mcr-9-Coharbouring Enterobacter hormaechei Isolated from Food of Animal Origin
por: Sadek, Mustafa, et al.
Publicado: (2020)

Stability and low induction propensity of cefiderocol against chromosomal AmpC β-lactamases of Pseudomonas aeruginosa and Enterobacter cloacae
por: Ito, Akinobu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9jsc037j4q4f4b44r9rksvkjpj